Hinge Health (HNGE) Insider Group Buys 533,228 Shares

LLC Insight Holdings Group Boosts Stake

LLC Insight Holdings Group bought 533,228 shares of Hinge Health, Inc. (NYSE: HNGE) on June 24, 2026. The stock is currently priced at $70.56, which is a significant drop from its previous close of $105.00. This purchase adds to Insight's existing stake in the company, reflecting its ongoing interest.

Insider Buying and Selling at Hinge Health, Inc.

This latest purchase follows several recent transactions by LLC Insight Holdings Group. Just two days prior, on June 22, the group sold 224,399 shares. They also bought 112,477 shares on June 23 and then acquired 1.47 million shares on June 29. These transactions illustrate a dynamic approach to managing their investment in Hinge Health, as Insight Holdings Group actively adjusts its position.

Analysts Set New Price Targets

Analysts are optimistic about Hinge Health's future. On October 16, 2026, Keybanc maintained an "Overweight" rating with a target price of $140. On October 12, Barclays also maintained an "Overweight" rating, raising its target to $110 from $100. Needham and Stifel both kept their "Buy" ratings, with targets of $115. This positive sentiment is supported by a consensus target price of $112.13 from 16 analysts, suggesting that they see potential for growth despite recent price fluctuations.

Stock Performance Context

Hinge Health is currently trading at $70.56, which is significantly lower than its 52-week high of $107.00. The stock's price has seen a considerable decline from its previous close of $105.00, raising questions about its near-term performance. Investors may be watching closely to see if the stock can recover in the coming months, especially with earnings expected on November 2, 2026.

What Hinge Health, Inc. Does

Hinge Health, Inc. focuses on creating a health system that automates care delivery, primarily for musculoskeletal issues. The company uses technology to provide personalized care, including AI-driven motion tracking and a unique nerve stimulation device. Serving mainly self-insured employers, Hinge Health aims to improve healthcare delivery efficiency.

What’s Next for Hinge Health?

With earnings coming up on November 2, 2026, investors will be keen to see how the company has performed and what guidance it offers for the future. Additionally, further insider transactions from LLC Insight Holdings Group could provide more insight into their confidence in Hinge Health's growth potential. The recent 13F filing indicates past positions and may not reflect current holdings, so the market will be watching closely for any updates.